                               SEQUENCE LISTING

<110> KITE PHARMA, INC.
 
<120> T CELL THERAPY

<130> K-1104-WO-PCT

<140> PCT/US2022/011606
<141> 2022-01-07

<150> 63/135,711
<151> 2021-01-10

<160> 2     

<170> PatentIn version 3.5

<210> 1
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr 
1               5                   10                  15      


Lys Gly 
        


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Gly Gly Gly Gly Ser 
1               5   


